CARBi - Genotype-Phenotype Project
Closed Solicitation Posted
- Solicitation number
- 75F401-24-Q-1277597
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Place of performance
- Silver Spring, Maryland 20903, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services is soliciting proposals for the "CARBi - Genotype-Phenotype Project 2024-2025" to evaluate the association between the expression of beta-lactamase enzymes, other proteins, and antimicrobial resistance in Gram-negative bacterial pathogens. The contract will have a one-year base period with two 12-month option periods. Offers are due by 11:59 PM EDT on August 28, 2024 via email. No specific evaluation criteria were provided in the solicitation notice.
This is an unrestricted solicitation, and the contracting agency intends to negotiate and solicit with only one source, Creighton University School of Medicine, under the authority of FAR 13.106-1(b)(1)(i). The NAICS code is 541690 - Other Scientific and Technical Consulting Services, with a $19.0 million size standard. The place of performance is Silver Spring, MD. The estimated value or budget range was not provided in the solicitation notice.
Notice text
2 versions
Update #2 · Latest ·
- Amendment 0001 - this amendment extends the response date to 8/30/2024 at 11:59PM EDT. It also provides a copy of the requirments document.
- Description:
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The Government intends to negotiate and solicit with only one source for Creighton University School of Medicine at 2500 California Plaza, Omaha, NE 6817-0002 under the authority of FAR 13.106-1(b)(1)(i). This is not a request for competitive proposals, however, any responsible offeror may submit a quote which will be given due consideration by the agency.
(i) This acquisition is issued as a Request for Quote (RFQ).
(ii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-05
(iii) For purposes of this acquisition, the associated NAICS code is 541690. The small business size standard is $19.0 million dollars. This action is being solicited as a sole source.
(iv) Line-Item Structure:The following is a list of line-item number(s) and items, quantities and units of measure, (including option(s), if applicable) and should be reflected in the Offeror’s quote/proposal:
Line Item 0001: CARBi - Genotype-Phenotype Project 2024-2025
Line Item 0002: 12-month option period
Line Item 0003: 12-month option period
(v) Specifications/Requirement: Evaluating the Association Between the Expression of β-lactamase Enzymes and Other Proteins and Antimicrobial Resistance (AMR) in Gram-Negative Bacterial Pathogens.
(vi) Delivery:One year from date of award with the inclusion of two 12-month option periods.
All Deliverables shall be submitted through email to the TPOC along with the COR.
Acceptance shall be performed at the delivery locations. The FOB point is DESTINATION.
(vii) The provision at 52.212-1, Instructions to Offerors – Commercial DEVIATION 2018-O0018, applies to this acquisition. The following addenda have been attached to this provision:
In addition to the requirements set for the in FAR 52.212-1, all offers responding to this solicitation must provide their business size in relation to the NAICS code contained in this solicitation and shall identify any socioeconomic categories to which they belong.
(viii) Evaluation Criteria - The specific evaluation criteria to be used are as follows: N/A
(ix) Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer.
(x) The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause.
(xi) The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following additional FAR clauses cited in this clause are applicable:
52.204-10 REPORTING EXECUTIVE COMPENSATION AND FIRST-TIER SUBCONTRACT AWARDS (JUN 2020)
52.209-6 PROTECTING THE GOVERNMENT’ INTEREST WHEN SUBCONTRACTING WITH CONTRACTORS DEBARRED, SUSPENDED, OR PROPOSED FOR DEBARMENT (NOV 2021)
52.219-28 POST-AWARD SMALL BUSINESS PROGRAM REREPRESENTATION (FEB 2024)
52.222-3 CONVICT LABOR (JUN 2003)
52.222-21 PROHIBITION OF SEGREGATED FACILITIES (APR 2015)
52.222-26 EQUAL OPPORTUNITY (SEP 2016)
52.222-35 EQUAL OPPORTUNITY FOR VETERANS (JUN 2020)
52.222-36 EQUAL OPPORTUNITY FOR WORKERS WITH DISABILITIES (JUN 2020)
52.222-37 EMPLOYMENT REPORTS ON SPECIAL DISABLED VETERANS, VETERANS OF THE VIETNAM ERA, AND OTHER ELIGIBLE VETERANS (JUN 2020)
52.222-50 COMBATING TRAFFICKING IN PERSONS (NOV 2021)
52.225-13 RESTRICTIONS ON CERTAIN FOREIGN PURCHASES (FEB 2021)
52.232-33 PAYMENT BY ELECTRONIC FUNDS TRANSFER—CENTRAL CONTRACTOR REGISTRATION (OCT 2018)
(xii) The following additional contract requirement(s) or terms and conditions apply:
52.204-7 SYSTEM FOR AWARD MANAGEMENT (OCT 2018)
52.204-13 SYSTEM FOR AWARD MANAGEMENT MAINTENANCE (OCT 2018)
52.204-16 COMMERCIAL AND GOVERNMENT ENTITY CODE REPORTING (JUL 2016)
52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE (JUL 2016)
52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (AUG 2019)
52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS (DEC 2013)
352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 15)
352.232-71 Electronic Submission of Payment Requests (FEB 2022)
352.239-73 Electronic and Information Technology Accessibility Notice (Dec 15)
352.239-74 Electronic and Information Technology Accessibility (Dec 2015)
(xiii) This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A
(xiv) Date, Time, and Place offers are due: Offers due via email to shannon.robinson@fda.hhs.gov and james.okeefeiii@fda.hhs.gov no later than (NLT) 11:59 PM EDT on 8/30/2024
(xv) Name and Telephone Number of the Individual to Contact for Information Regarding the Solicitation:For additional information contact Shannon Robinson at 301-796-5069 and James O’Keefe at 301-796-7371
Update #1 ·
- Description:
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The Government intends to negotiate and solicit with only one source for Creighton University School of Medicine at 2500 California Plaza, Omaha, NE 6817-0002 under the authority of FAR 13.106-1(b)(1)(i). This is not a request for competitive proposals, however, any responsible offeror may submit a quote which will be given due consideration by the agency.
(i) This acquisition is issued as a Request for Quote (RFQ).
(ii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-05
(iii) For purposes of this acquisition, the associated NAICS code is 541690. The small business size standard is $19.0 million dollars. This action is being solicited as a sole source.
(iv) Line-Item Structure:The following is a list of line-item number(s) and items, quantities and units of measure, (including option(s), if applicable) and should be reflected in the Offeror’s quote/proposal:
Line Item 0001: CARBi - Genotype-Phenotype Project 2024-2025
Line Item 0002: 12-month option period
Line Item 0003: 12-month option period
(v) Specifications/Requirement: Evaluating the Association Between the Expression of β-lactamase Enzymes and Other Proteins and Antimicrobial Resistance (AMR) in Gram-Negative Bacterial Pathogens.
(vi) Delivery:One year from date of award with the inclusion of two 12-month option periods.
All Deliverables shall be submitted through email to the TPOC along with the COR.
Acceptance shall be performed at the delivery locations. The FOB point is DESTINATION.
(vii) The provision at 52.212-1, Instructions to Offerors – Commercial DEVIATION 2018-O0018, applies to this acquisition. The following addenda have been attached to this provision:
In addition to the requirements set for the in FAR 52.212-1, all offers responding to this solicitation must provide their business size in relation to the NAICS code contained in this solicitation and shall identify any socioeconomic categories to which they belong.
(viii) Evaluation Criteria - The specific evaluation criteria to be used are as follows: N/A
(ix) Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer.
(x) The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause.
(xi) The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following additional FAR clauses cited in this clause are applicable:
52.204-10 REPORTING EXECUTIVE COMPENSATION AND FIRST-TIER SUBCONTRACT AWARDS (JUN 2020)
52.209-6 PROTECTING THE GOVERNMENT’ INTEREST WHEN SUBCONTRACTING WITH CONTRACTORS DEBARRED, SUSPENDED, OR PROPOSED FOR DEBARMENT (NOV 2021)
52.219-28 POST-AWARD SMALL BUSINESS PROGRAM REREPRESENTATION (FEB 2024)
52.222-3 CONVICT LABOR (JUN 2003)
52.222-21 PROHIBITION OF SEGREGATED FACILITIES (APR 2015)
52.222-26 EQUAL OPPORTUNITY (SEP 2016)
52.222-35 EQUAL OPPORTUNITY FOR VETERANS (JUN 2020)
52.222-36 EQUAL OPPORTUNITY FOR WORKERS WITH DISABILITIES (JUN 2020)
52.222-37 EMPLOYMENT REPORTS ON SPECIAL DISABLED VETERANS, VETERANS OF THE VIETNAM ERA, AND OTHER ELIGIBLE VETERANS (JUN 2020)
52.222-50 COMBATING TRAFFICKING IN PERSONS (NOV 2021)
52.225-13 RESTRICTIONS ON CERTAIN FOREIGN PURCHASES (FEB 2021)
52.232-33 PAYMENT BY ELECTRONIC FUNDS TRANSFER—CENTRAL CONTRACTOR REGISTRATION (OCT 2018)
(xii) The following additional contract requirement(s) or terms and conditions apply:
52.204-7 SYSTEM FOR AWARD MANAGEMENT (OCT 2018)
52.204-13 SYSTEM FOR AWARD MANAGEMENT MAINTENANCE (OCT 2018)
52.204-16 COMMERCIAL AND GOVERNMENT ENTITY CODE REPORTING (JUL 2016)
52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE (JUL 2016)
52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (AUG 2019)
52.232-40 PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS (DEC 2013)
352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 15)
352.232-71 Electronic Submission of Payment Requests (FEB 2022)
352.239-73 Electronic and Information Technology Accessibility Notice (Dec 15)
352.239-74 Electronic and Information Technology Accessibility (Dec 2015)
(xiii) This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A
(xiv) Date, Time, and Place offers are due: Offers due via email to shannon.robinson@fda.hhs.gov and james.okeefeiii@fda.hhs.gov no later than (NLT) 11:59 PM EDT on 8/28/2024
(xv) Name and Telephone Number of the Individual to Contact for Information Regarding the Solicitation:For additional information contact Shannon Robinson at 301-796-5069 and James O’Keefe at 301-796-7371
Files
| File | Type | Posted |
|---|---|---|
| SOW_081524.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity